Gene170NCBI Gene
AFA: ankyloblepharon filiforme adnatum
Cite this record
ConductScience Library. AFA: ankyloblepharon filiforme adnatum. Genes, record 170. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/170
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
- Symbol
- AFA
- Name
- ankyloblepharon filiforme adnatum
- NCBI Gene ID
- 170
- Type
- unknown
Source NCBI Gene
NIH grants128
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AFA papers | Newest fiscal year |
|---|---|---|---|
| P30DK063491 | Diabetes Research Center (DRC) | 2 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 2 | 2025 |
| T32ES012870 | Graduate and Postdoctoral Training in Environmental Health Science and Toxicology | 2 | 2025 |
| P2CHD050924 | Carolina Population Center | 1 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 1 | 2025 |
| P30CA071789 | University of Hawaii Cancer Center CCSG | 1 | 2025 |
| T32HL007055 | Cardiovascular Epidemiology Training Grant | 1 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 1 | 2025 |
| ZIAHG200362 | Genetic epidemiology of complex diseases | 1 | 2025 |
| R01HL059367 | Epidemiology of Venous Thrombosis and Pulmonary Embolism | 1 | 2024 |
Source NIH's project files
Papers201
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating NMR Restraints into Coarse-Grained Simulations: Toward Accurate Conformational Ensembles of Complex Protein Systems. | J Am Chem Soc | 2026 | 41851975 | PubTator, text mining | PubMed |
| Current pattern of antibiotic resistance and molecular characterization of virulence genes in Klebsiella pneumoniae obtained from urinary tract infection (UTIs) patients, Peshawar. | PLoS One | 2025 | 40208900 | PubTator, text mining | PubMed |
| Investigation of virulence factor genes and biofilm formation of antibiotic resistant clinical E.coli isolates. | Microb Pathog | 2025 | 39725043 | PubTator, text mining | PubMed |
| Comparative analysis of virulence gene profiles of Escherichia coli from human and non-human sources in Rivers State, Nigeria. | Access Microbiol | 2024 | 39130738 | PubTator, text mining | PubMed |
| Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran. | J Infect Dev Ctries | 2024 | 38865401 | PubTator, text mining | PubMed |
| Wheat Pm55 alleles exhibit distinct interactions with an inhibitor to cause different powdery mildew resistance. | Nat Commun | 2024 | 38218848 | PubTator, text mining | PubMed |
| Dissection of a rapidly evolving wheat resistance gene cluster by long-read genome sequencing accelerated the cloning of Pm69. | Plant Commun | 2024 | 37415333 | PubTator, text mining | PubMed |
| Clonal and plasmidic dissemination of critical antimicrobial resistance genes through clinically relevant ExPEC and APEC-like lineages (ST) in the dairy cattle population of Québec, Canada. | Front Microbiol | 2023 | 38304859 | PubTator, text mining | PubMed |
| Biofilm Formation by Escherichia coli Isolated from Urinary Tract Infections from Aguascalientes, Mexico. | Microorganisms | 2023 | 38138002 | PubTator, text mining | PubMed |
| Comparative study of virulence potential, phylogenetic origin, CRISPR-Cas regions and drug resistance of Escherichia coli isolates from urine and other clinical materials. | Front Microbiol | 2023 | 38094634 | PubTator, text mining | PubMed |
None in this release
- Proteins
- Patents
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/170
GET https://conductscience.org/api/genes/v1/170/grants?page=2